SOAR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SOAR is not a good buy right now. Despite a short-term momentum uptick (positive/expanding MACD), the broader trend remains bearish (SMA_200 > SMA_20 > SMA_5) and price is already near a key resistance zone (R1 0.685) with limited upside room versus downside to support (pivot 0.56). With no proprietary buy signals and very weak latest-quarter revenue trends, the risk/reward does not favor an impatient buyer at the current price (0.647).
Trend/structure: Bearish moving-average stack (SMA_200 > SMA_20 > SMA_5) indicates the dominant trend is still down. Momentum: MACD histogram is positive (0.0359) and expanding, signaling a short-term rebound attempt. RSI(6) ~69.37 is near the upper end of neutral, suggesting the bounce is getting extended rather than offering a fresh low-risk entry. Levels: Pivot 0.56 is the nearest important support; below that S1 ~0.436. Resistance sits at R1 ~0.685 then R2 ~0.761; with price ~0.647, it’s closer to resistance than support, which weakens the immediate entry setup. Market context: S&P 500 is down (-0.52%), adding mild headwind.
Intellectia Proprietary Trading Signals Intellectia Proprietary Trading Signals
Pattern-based projection (provided): indicates only a 50% chance of a small next-day move (0.64%) and 1.78% next-week, with a higher next-month estimate (21.62%), but without confirmation signals this is not a strong immediate-entry setup.
Technical momentum is improving short-term (MACD positive and expanding). Gross margin rose sharply YoY (67.72%), suggesting potential cost/mix improvements. No notable negative insider or hedge fund trend flags (both neutral).
Primary trend remains bearish (MA stack), and the price is near resistance (R1 ~0.685), which can cap near-term upside. Latest quarter shows extreme revenue contraction (down ~99% YoY), which is a major fundamental overhang. No recent news catalysts in the past week to drive a breakout, and pre-market indicated weakness (-1.40%).
Latest reported quarter: 2025/Q3. Revenue dropped to ~381,000 (down ~99.01% YoY), indicating severe top-line contraction. Net income fell to ~7,145,000 (down ~261.10% YoY) and EPS fell to 1.2 (down ~131.91% YoY), reflecting deteriorating profitability/earnings power versus last year. Gross margin increased to ~67.72% (up ~307.22% YoY), but margin expansion is not enough to offset the scale of the revenue decline; the growth trend is decisively negative.
No analyst rating or price target change data was provided, so Wall Street sentiment cannot be confirmed from the dataset. With the available info, the 'pro' case is limited to a short-term technical bounce and margin improvement, while the 'con' case is dominated by collapsing revenue, bearish longer-term trend structure, and lack of identifiable catalysts.
